This recognition reflects our continued investment in transatlantic collaboration to advance precision medicine. Our US headquarters in Newport, NJ, strengthens our ability to support clients, scale our team, and accelerate the delivery of data-led solutions that improve testing and treatment for patients globally.
As Duncan Edwards OBE, CEO of BritishAmerican Business, shared:
“This year’s TAG winners exemplify the resilience, innovation, and entrepreneurial spirit that continues to drive transatlantic trade and investment. Their success creates jobs, fuels growth, and reinforces the importance of the economic partnership between our two countries.”
Ryan Keeling, CEO at Diaceutics, added:
“Winning the TAG Awards for UK Midsize Investment in the US is a proud moment for us and a testament to our relentless growth and strategic expansion in the US. Following the opening of our US office earlier this year and our continued recruitment of top talent, this recognition reinforces our commitment to driving innovation and excellence in the market.”
Thank you to BritishAmerican Business for this honour, and to our amazing team and partners who share our mission to transform patient outcomes through innovation.
